Vaxcyte Stock In The News
| PCVX Stock | USD 70.97 1.54 2.12% |
Our overall analysis of Vaxcyte's news coverage and content from conventional and social sources shows investors' bearish mood towards Vaxcyte. The specific impact of Vaxcyte news on its stock price will depend on a range of factors, including the nature and significance of the news report and investors' perceptions of Vaxcyte's overall financial health and prospects. It also depends on the type and quality of a news publisher.
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using Vaxcyte headlines in addition to utilizing other, more conventional financial analysis modules. Check out Vaxcyte Backtesting and Vaxcyte Hype Analysis. For more information on how to buy Vaxcyte Stock please use our How to Invest in Vaxcyte guide.
Vaxcyte |
Vaxcyte Today Top News and Investor Outlook
Vaxcyte Past News Timeline
Popular news outlets such as MarketWatch, Bloomberg, or Reuters provide Vaxcyte and other traded companies coverage with news coverage. We help investors stay connected with Vaxcyte headlines for the 7th of June to make an informed investment decision based on correlating the impacts of news items on Vaxcyte Stock performance. Please note that trading solely based on the Vaxcyte hype is not for everyone as timely availability and quick action are needed to avoid losses.
Vaxcyte stock price changes are notoriously difficult to predict based exclusively on its news coverage or social hype. Still, the Vaxcyte earnings-per-share ratio is a good starting point for gauging a company's future prospects. If a firm's EPS rises and meets or even beats consensus forecasts, its shares stand to increase. However, some very sophisticated investors can spot management manipulation of EPS through actions such as buybacks.
Far too much social signal, news, headlines, and media speculation about Vaxcyte that are available to investors today. That information is available publicly through Vaxcyte media outlets and privately through word of mouth or via Vaxcyte internal channels. However, regardless of the origin, that massive amount of Vaxcyte data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Vaxcyte news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Vaxcyte relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Vaxcyte's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Vaxcyte alpha.
Vaxcyte Largest EPS Surprises
Earnings surprises can significantly impact Vaxcyte's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2021-08-11 | 2021-06-30 | -0.52 | -0.46 | 0.06 | 11 | ||
2021-05-11 | 2021-03-31 | -0.48 | -0.41 | 0.07 | 14 | ||
2022-11-07 | 2022-09-30 | -0.84 | -0.93 | -0.09 | 10 | ||
2022-08-08 | 2022-06-30 | -0.69 | -0.8 | -0.11 | 15 | ||
2023-05-08 | 2023-03-31 | -0.83 | -0.7 | 0.13 | 15 | ||
2021-03-29 | 2020-12-31 | -0.54 | -0.41 | 0.13 | 24 |
Vaxcyte Stock Latest Headlines
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using conventional financial analysis. Below is the latest headlines and news related to Vaxcyte Stock. The global stock market is bullish. About 70% of major world exchanges and indexes are currently up. See today's market update for more information.
5th of June 2024
Vaxcyte executive sells over 120k in company stock at investing.com
3rd of June 2024
Disposition of 117 shares by Pickering Grant of Vaxcyte at 73.46 subject to Rule 16b-3 at MacroaxisInsider
23rd of May 2024
Disposition of 15000 shares by Pickering Grant of Vaxcyte at 2.03 subject to Rule 16b-3 at MacroaxisInsider
20th of May 2024
Disposition of 4456 shares by Guggenhime Andrew of Vaxcyte at 75.46 subject to Rule 16b-3 at MacroaxisInsider
15th of May 2024
Nicholas Investment Partners LP Trims Stock Position in Vaxcyte, Inc. - MarketBeat at news.google.com
9th of May 2024
Vaxcyte GAAP EPS of -0.85 at seekingalpha.com
6th of May 2024
Vaxcyte, Inc. Shares Bought by New York State Common Retirement Fund - Defense World at news.google.com
3rd of May 2024
Vaxcyte COO sells over 184k in company stock at investing.com
1st of May 2024
Disposition of tradable shares by Pickering Grant of VaxcyteInc at 63.84 subject to Rule 1... at MacroaxisInsider
26th of April 2024
Insider Selling Vaxcyte, Inc. CEO Sells 15000 Shares of Stock - Defense World at news.google.com
23rd of April 2024
Disposition of 15000 shares by Pickering Grant of VaxcyteInc at 1.79 subject to Rule 16b-3 at Pickering Grant
18th of April 2024
Disposition of 376 shares by Guggenhime Andrew of VaxcyteInc at 61.902 subject to Rule 16b... at Guggenhime Andrew
17th of April 2024
Disposition of 3551 shares by Wassil Jim of VaxcyteInc at 5.35 subject to Rule 16b-3 at Wassil Jim
12th of April 2024
Disposition of 30000 shares by Pickering Grant of VaxcyteInc at 79.03 subject to Rule 16b-... at Pickering Grant
1st of April 2024
Disposition of tradable shares by Pickering Grant of VaxcyteInc at 68.1 subject to Rule 16... at MacroaxisInsider
25th of March 2024
Disposition of 15000 shares by Pickering Grant of VaxcyteInc at 1.79 subject to Rule 16b-3 at Pickering Grant
18th of March 2024
Disposition of 236 shares by Guggenhime Andrew of VaxcyteInc at 69.642 subject to Rule 16b... at Guggenhime Andrew
15th of March 2024
Disposition of 1484 shares by Wassil Jim of VaxcyteInc at 69.7 subject to Rule 16b-3 at Wassil Jim
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Vaxcyte in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Vaxcyte's short interest history, or implied volatility extrapolated from Vaxcyte options trading.
Additional Tools for Vaxcyte Stock Analysis
When running Vaxcyte's price analysis, check to measure Vaxcyte's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vaxcyte is operating at the current time. Most of Vaxcyte's value examination focuses on studying past and present price action to predict the probability of Vaxcyte's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vaxcyte's price. Additionally, you may evaluate how the addition of Vaxcyte to your portfolios can decrease your overall portfolio volatility.